THE NICKLES GROUP, LLC for UCB, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to reimbursement of self-administered drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO New | White House Office of Management and Budget, Associate Director of Health Programs; Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff Member. |
Medicare/Medicaid MMM
Issues related to the implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to the COVID-19 access to Part B drugs; issues related to the Most Favored Nation (MFN) and rebate rule; H.R. 133, the Consolidated Appropriations Act of 2021, issues related to reimbursement of self-administered drugs; issues related to the importation of prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
Taxation/Internal Revenue Code TAX
Monitor implementation of The Tax Cut and Jobs Act, as it relates to multinational corporations. H.R. 133, the Consolidated Appropriations Act of 2021, as it relates to corporate taxes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.